Literature DB >> 2293894

Caries development in children in relation to the presence of mutans streptococci in dental plaque and of serum antibodies against whole cells and protein antigen I/II of Streptococcus mutans.

J Tenovuo1, O P Lehtonen, A S Aaltonen.   

Abstract

Twenty-eight children, aged 0.8-3.8 years, were studied with respect to the presence of mutans streptococci (MS) in dental plaque and the amount and avidity of specific serum IgG and IgM antibodies against whole cells and streptococcal protein antigen I/II (SA I/II) of Streptococcus mutans. The presence or absence of MS in dental plaque at the median age of 1.9 years predicted the caries development during a 2.7-year follow-up period with a sensitivity and specificity of 73 and 92%, respectively. The caries predictive value of a positive finding of MS at this age was as high as 92%. Almost all children had detectable amounts of serum IgG and IgM antibodies against whole cells and SA I/II of S. mutans, irrespective of the presence of detectable levels of this bacterium in dental plaque. These antibodies increased with age. The antibody levels did not differ significantly between children who were MS-negative or MS-positive. However, in MS-free children as well as in the whole study group, total specific and high-avidity antibodies of IgG class against whole cells correlated positively with antibodies against SA I/II. In MS-infected children such an association was observed for IgM but not for IgG antibodies. This different serum antibody profile in MS-negative and -positive children may be related to the mode of immunization with S. mutans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293894     DOI: 10.1159/000261240

Source DB:  PubMed          Journal:  Caries Res        ISSN: 0008-6568            Impact factor:   4.056


  11 in total

1.  An evaluation of serum albumin, root caries, and other covariates in Gullah African Americans with type-2 diabetes.

Authors:  Nicole M Marlow; Elizabeth H Slate; Dipankar Bandyopadhyay; Jyotika K Fernandes; Carlos F Salinas
Journal:  Community Dent Oral Epidemiol       Date:  2010-11-10       Impact factor: 3.383

2.  Inhibition of interleukin-2 by a Gram-positive bacterium, Streptococcus mutans.

Authors:  L M Plitnick; J A Banas; D M Jelley-Gibbs; J O'neil; T Christian; S P Mudzinski; E J Gosselin
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

3.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

4.  Salivary defense factors and oral health in patients with common variable immunodeficiency.

Authors:  V Kirstilä; J Tenovuo; O Ruuskanen; J Nikoskelainen; K Irjala; P Vilja
Journal:  J Clin Immunol       Date:  1994-07       Impact factor: 8.317

5.  Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.

Authors:  Rebekah A Robinette; Kyle P Heim; Monika W Oli; Paula J Crowley; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2013-11-16       Impact factor: 3.641

6.  Effects of xylitol wipes on cariogenic bacteria and caries in young children.

Authors:  L Zhan; J Cheng; P Chang; M Ngo; P K Denbesten; C I Hoover; J D B Featherstone
Journal:  J Dent Res       Date:  2012-07       Impact factor: 6.116

7.  Unexpectedly high levels of some presumably protective secretory immunoglobulin A antibodies to dental plaque bacteria in salivas of both caries-resistant and caries-susceptible subjects.

Authors:  H Hocini; S Iscaki; J P Bouvet; J Pillot
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

9.  Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of the Streptococcus mutans P1 surface protein.

Authors:  Milene Tavares Batista; Renata D Souza; Ewerton L Ferreira; Rebekah Robinette; Paula J Crowley; Juliana F Rodrigues; L Jeannine Brady; Luís C S Ferreira; Rita C C Ferreira
Journal:  Infect Immun       Date:  2014-09-15       Impact factor: 3.441

10.  Identification of antigenic epitopes in a surface protein antigen of Streptococcus mutans in humans.

Authors:  K Matsushita; T Nisizawa; S Nagaoka; M Kawagoe; T Koga
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.